Cite
MLA Citation
A. Avigdor et al.. “BASELINE CLINICAL AND PET‐CT TUMOR BURDEN PARAMETERS DO NOT PREDICT OUTCOME OF RELAPSE/REFRACTORY AGGRESSIVE B CELL LYMPHOMA PATIENTS TREATED WITH ANTI‐CD19 CAR T‐CELLS.” Hematological oncology, vol. 37, n.d., pp. 504–505. http://access.bl.uk/ark:/81055/vdc_100086191706.0x00004f